In Conversation with Dr. Jehanzeb "JB" Bilal
BrandStory
SRQ DAILY TUESDAY DINING AND FOOD EDITION
TUESDAY JAN 18, 2022 |
In the January 2022 edition of SRQ Magazine, we interviewed Dr. Jehanzeb “JB” Bilal of The Renal Hypertension Center as part of our In Conversation marketing feature with top doctor honorees on trends in medicine, health and wellness. Below is an excerpt published in the magazine in which Dr. Bilal shares his insights with SRQ readers on the latest developments in medicine.
Dr. Bilal, what are some of the cutting edge treatments in your field?
We have seen some tremendous developments, especially in the last 10 years or so. We've seen a lot of new medications that have revolutionized nephrology practice recently. The biggest, SGLT2 inhibitors, are medications that were initially brought on as diabetes medication, but we noticed they have profound benefits in reducing mortality in patients with kidney disease, heart disease, as well as diabetes. Congestive heart failure is a big problem in people with kidney disease and heart disease. These ailments are the biggest drivers of Medicare money and health expenditure, so the medication has huge implications there. We are in a great position to help a patient who could decline potentially by just having the old school treatments available to them. With this medication we've seen excellent results.
Renal Hypertension Center, Sarasota Location: 3801 Bee Ridge Rd., Ste. 1 Sarasota, FL 34233 Phone: 941-922-4498 Fax: 941-922-4571
« View The Tuesday Jan 18, 2022 SRQ Daily Edition
« Back To SRQ Daily Archive